Locations
Cambridge, MA, USA · Cambridge, MA, USA
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Other
founded in
2001
Mersana Therapeutics is focused on discovering and developing innovative antibody-drug conjugates (ADCs) to treat cancer. Their proprietary technology platforms enable the creation of highly differentiated ADCs with both cytotoxic and immunostimulatory payloads, aimed at overcoming the limitations of first-generation platforms. Mersana's pipeline includes multiple ADCs designed to improve efficacy and tolerability, addressing significant unmet medical needs in oncology. The company is committed to advancing cancer treatment through a multi-pronged strategy, leveraging their advanced technology to enhance patient outcomes.
Something looks off?